Kentucky 2025 Regular Session

Kentucky House Bill HB571 Latest Draft

Bill / Introduced Version

                            UNOFFICIAL COPY  	25 RS BR 1303 
Page 1 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
AN ACT relating to medicinal cannabis. 1 
Be it enacted by the General Assembly of the Commonwealth of Kentucky: 2 
Section 1.   KRS 218B.010 is amended to read as follows: 3 
For the purposes of this chapter, unless the context otherwise requires: 4 
(1) "Bona fide practitioner-patient relationship" means a treating or consulting 5 
relationship, during the course of which a medicinal cannabis practitioner has: 6 
(a) Completed an initial in-person examination and assessment of the patient's 7 
medical history and current medical condition which shall include a review 8 
of: 9 
1. The patient's medical records for the previous twelve (12) months; 10 
2. All other available medical records relevant to the patient's qualifying 11 
medical condition; 12 
3. Any medications that the patient is currently taking; and 13 
4. Any other possible risks or side effects that may be associated with the 14 
use of medicinal cannabis; 15 
(b) Consulted with the patient with respect to the possible medical, therapeutic, 16 
and palliative properties of medicinal cannabis; 17 
(c) Advised the patient of the possible risks and side effects associated with the 18 
use of medicinal cannabis, including possible interactions between medicinal 19 
cannabis and any other drug or medication that the patient is taking at that 20 
time; and 21 
(d) Established an expectation that he or she will provide follow-up care and 22 
treatment to the patient in accordance with administrative regulations 23 
promulgated pursuant to KRS 218B.050(10); 24 
(2) "Cabinet" means the Cabinet for Health and Family Services; 25 
(3) "Cannabis business" means an entity licensed under this chapter as a cultivator, 26 
dispensary, processor, producer, or safety compliance facility; 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 2 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
(4) "Cannabis business agent" means a principal officer, board member, employee, 1 
volunteer, or agent of a cannabis business; 2 
(5) "Cardholder" means: 3 
(a) A registered qualified patient, designated caregiver, or visiting qualified 4 
patient who has applied for, obtained, and possesses a valid registry 5 
identification card issued by the cabinet; or 6 
(b) A visiting qualified patient who has obtained and possesses: 7 
1. A valid out-of-state registry identification card; and 8 
2. Documentation of having been diagnosed with a qualifying medical 9 
condition; 10 
(6) "Cultivator" means an entity licensed as such under KRS 218B.080, 218B.085, and 11 
218B.090; 12 
(7) "Cultivator agent" means a principal officer, board member, employee, volunteer, 13 
or agent of a cultivator; 14 
(8) "Designated caregiver" means a person who has registered as such with the cabinet 15 
under KRS 218B.055 and 218B.060; 16 
(9) "Dispensary" means an entity licensed as such under KRS 218B.080, 218B.085, 17 
and 218B.090; 18 
(10) "Dispensary agent" means a principal officer, board member, employee, volunteer, 19 
or agent of a dispensary; 20 
(11) "Disqualifying felony offense" means: 21 
(a) A felony offense that resulted in the person being classified by the 22 
Department of Corrections as a violent offender under KRS 439.3401; or 23 
(b) A violation of a state or federal controlled substance law that was classified as 24 
a felony in the jurisdiction where the person was convicted, except: 25 
1. An offense for which the sentence, including any term of probation, 26 
incarceration, or supervised release, was completed five (5) or more 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 3 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
years earlier; or 1 
2. An offense that, as determined by the cabinet, consisted of conduct for 2 
which this chapter would likely have prevented a conviction, but the 3 
conduct either occurred prior to the enactment of this chapter or was 4 
prosecuted by an authority other than the Commonwealth of Kentucky; 5 
(12) "Enclosed, locked facility" means an indoor growing space such as a room, 6 
greenhouse, building, or other indoor enclosed area that is maintained and operated 7 
by a cultivator or producer and is equipped with locks and other security devices 8 
that permit access only by authorized agents of the cultivator or producer, as 9 
required by the cabinet; 10 
(13) "Growth area" has the same meaning as an enclosed, locked facility; 11 
(14) "Marijuana" has the same meaning as in KRS 218A.010; 12 
(15) "Medicinal cannabis": 13 
(a) Means marijuana as defined in KRS 218A.010 when cultivated, harvested, 14 
processed, produced, transported, dispensed, distributed, sold, possessed, or 15 
used in accordance with this chapter; 16 
(b) Includes medicinal cannabis products and raw plant material; and 17 
(c) Does not include industrial hemp or industrial hemp products as defined in 18 
KRS 260.850; 19 
(16) "Medicinal cannabis accessories" means any equipment, product, or material of any 20 
kind which is used, intended for use, or designed for use in the preparing, storing, 21 
using, or consuming medicinal cannabis in accordance with this chapter; 22 
(17) "Medicinal cannabis practitioner" means a physician or an advanced practice 23 
registered nurse who is authorized to prescribe controlled substances under KRS 24 
314.042, who is authorized by his or her state licensing board to provide written 25 
certifications pursuant to KRS 218B.050; 26 
(18) "Medicinal cannabis product": 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 4 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
(a) Means any compound, manufacture, salt, derivative, mixture, or preparation 1 
of any part of the plant Cannabis sp., its seeds or its resin; or any compound, 2 
mixture, or preparation which contains any quantity of these substances when 3 
cultivated, harvested, processed, produced, transported, dispensed, distributed, 4 
sold, possessed, or used in accordance with this chapter; and 5 
(b) Does not include industrial hemp products as defined in KRS 260.850; 6 
(19) "Minor" means a person less than eighteen (18) years of age; 7 
(20) "Out-of-state registry identification card" means a registry identification card, or an 8 
equivalent document, that was issued pursuant to the laws of another state, district, 9 
territory, commonwealth, or insular possession of the United States; 10 
(21) "Processor" means an entity licensed as such under KRS 218B.080, 218B.085, and 11 
218B.090; 12 
(22) "Processor agent" means a principal officer, board member, employee, volunteer, or 13 
agent of a processor; 14 
(23) "Producer" means an entity licensed as such under KRS 218B.080, 218B.085, and 15 
218B.090; 16 
(24) "Producer agent" means a principal officer, board member, employee, volunteer, or 17 
agent of a producer; 18 
(25) "Qualified patient" means a person who has obtained a written certification from a 19 
medicinal cannabis practitioner with whom he or she has a bona fide practitioner-20 
patient relationship; 21 
(26) "Qualifying medical condition" means any of the following: 22 
(a) Acquired immunodeficiency syndrome (AIDS); 23 
(b) Amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease; 24 
(c) Cachexia or wasting syndrome; 25 
(d) [Any type or form of ]Cancer regardless of type, form, or stage; 26 
(e) Chronic nausea or cyclical vomiting syndrome that has proven resistant to 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 5 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
other conventional medical treatments; 1 
(f)[(b)] Chronic, severe, intractable, or debilitating pain; 2 
(g) Crohn's disease; 3 
(h)[(c)] Epilepsy or any other intractable seizure disorder; 4 
(i) Fibromyalgia; 5 
(j) Glaucoma; 6 
(k) Hepatitis C; 7 
(l) Human immunodeficiency virus (HIV); 8 
(m) Huntington's disease; 9 
(n)[(d)] Multiple sclerosis, muscle spasms, or spasticity; 10 
(o) Muscular dystrophy; 11 
(p) Neuropathies; 12 
(q) Parkinson's disease; 13 
[(e) Chronic nausea or cyclical vomiting syndrome that has proven resistant to 14 
other conventional medical treatments;] 15 
(r)[(f)] Post-traumatic stress disorder;[ and] 16 
(s) Severe arthritis; 17 
(t) Sickle cell disease; 18 
(u) Any terminal illness as defined in KRS 217.5401; and 19 
(v)[(g)] Any other medical condition or disease for which the Kentucky Center 20 
for Cannabis established in KRS 164.983, or its successor, determines that 21 
sufficient scientific data and evidence exists to demonstrate that an individual 22 
diagnosed with that condition or disease is likely to receive medical, 23 
therapeutic, or palliative benefits from the use of medicinal cannabis; 24 
(27) "Raw plant material": 25 
(a) Means the trichome-covered part of the female plant Cannabis sp. or any 26 
mixture of shredded leaves, stems, seeds, and flowers of the Cannabis sp. 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 6 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
plant; and 1 
(b) Does not include plant material obtained from industrial hemp as defined in 2 
KRS 260.850; 3 
(28) "Registered qualified patient" means a qualified patient who has applied for, 4 
obtained, and possesses a valid registry identification card issued by the cabinet; 5 
(29) "Registry identification card" means a document issued by the cabinet that 6 
identifies a person as a registered qualified patient, visiting qualified patient, or 7 
designated caregiver; 8 
(30) "Safety compliance facility" means an entity licensed as such under KRS 218B.080, 9 
218B.085, and 218B.090; 10 
(31) "Safety compliance facility agent" means a principal officer, board member, 11 
employee, volunteer, or agent of a safety compliance facility; 12 
(32) "Seedling" means a medicinal cannabis plant that has no flowers and is not taller 13 
than eight (8) inches; 14 
(33) "Serious violation" means: 15 
(a) Any violation of this chapter or any administrative regulation promulgated 16 
thereunder that is capable of causing death or which causes serious and 17 
prolonged disfigurement, prolonged impairment of health, or prolonged loss 18 
or impairment of the function of any bodily organ; 19 
(b) The diversion of medicinal cannabis for use not regulated pursuant to this 20 
chapter; or 21 
(c) Any act that would constitute a violation of KRS 218A.1421; 22 
(34) "Smoking" means the inhalation of smoke produced from the combustion of raw 23 
plant material when ignited by a flame; 24 
(35) "State licensing board" means: 25 
(a) The Kentucky Board of Medical Licensure; or 26 
(b) The Kentucky Board of Nursing; 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 7 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
(36) "Telehealth" has the same meaning as in KRS 211.332; 1 
(37) "Use of medicinal cannabis": 2 
(a) Includes the acquisition, administration, possession, transfer, transportation, 3 
or consumption of medicinal cannabis or medicinal cannabis accessories by a 4 
cardholder in accordance with this chapter; and 5 
(b) Does not include: 6 
1. Cultivation of marijuana by a cardholder; 7 
2. The use or consumption of marijuana by smoking; or 8 
3. The use of industrial hemp or industrial hemp products as defined in 9 
KRS 260.850; 10 
(38) "Visiting qualified patient" means a person who has registered as such through the 11 
cabinet as required under this chapter or who possesses a valid out-of-state registry 12 
identification card and documentation of having been diagnosed with a qualifying 13 
medical condition; and 14 
(39) "Written certification" means a document dated and signed by a medicinal cannabis 15 
practitioner, that: 16 
(a) States, that in the medicinal cannabis practitioner's professional medical 17 
opinion, the patient may receive medical, therapeutic, or palliative benefit 18 
from the use of medicinal cannabis; 19 
(b) Specifies the qualifying medical condition or conditions for which the 20 
medicinal cannabis practitioner believes the patient may receive medical, 21 
therapeutic, or palliative benefit; and 22 
(c) Affirms that the medicinal cannabis practitioner has a bona fide practitioner-23 
patient relationship with the patient. 24 
Section 2.   KRS 218B.025 is amended to read as follows: 25 
(1) A registered qualified patient, except as provided in subsection (2) of this section 26 
and KRS 218B.035, shall not be subject, under the laws of the Commonwealth, to 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 8 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
arrest, prosecution, or denial of any right or privilege, including but not limited to a 1 
civil penalty or disciplinary action by a court or occupational or professional 2 
licensing board, for the use of medicinal cannabis, if the registered qualified patient 3 
does not possess more than: 4 
(a) An amount of medicinal cannabis determined by the cabinet to constitute an 5 
uninterrupted thirty (30) day supply at his or her residence, except as 6 
permitted under Section 7 of this Act; 7 
(b) An amount of medicinal cannabis in excess of a thirty (30) day supply at his 8 
or her residence, in accordance with administrative regulations promulgated 9 
pursuant to KRS 218B.140(1)(c)6.; or 10 
(c) An amount of medicinal cannabis determined by the cabinet to constitute an 11 
uninterrupted ten (10) day supply on his or her person, except that an amount 12 
greater than a ten (10) day supply may be transported by a registered qualified 13 
patient from a dispensary to his or her residence if the medicinal cannabis is 14 
contained in a sealed package that requires at least a two (2) step process for 15 
initial opening. 16 
(2) A registered qualified patient who is under eighteen (18) years of age shall not be 17 
permitted to possess, purchase, or acquire medicinal cannabis and shall only engage 18 
in the use of medicinal cannabis with the assistance of a designated caregiver who 19 
is the registered qualified patient's parent or legal guardian responsible for 20 
providing consent for medical treatment. 21 
(3) A visiting qualified patient shall not be subject, under the laws of the 22 
Commonwealth, to arrest, prosecution, or denial of any right or privilege, including 23 
but not limited to civil penalty or disciplinary action by a court or occupational or 24 
professional licensing board, for the use of medicinal cannabis, if the visiting 25 
qualified patient does not possess more than an amount of medicinal cannabis 26 
determined by the cabinet to constitute an uninterrupted ten (10) day supply on his 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 9 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
or her person. 1 
(4) A designated caregiver shall not be subject, under the laws of the Commonwealth, 2 
to arrest, prosecution, or denial of any right or privilege, including but not limited to 3 
civil penalty or disciplinary action by a court or occupational or professional 4 
licensing board, for assisting a registered qualified patient to whom the designated 5 
caregiver is connected through the cabinet's registration process with the use of 6 
medicinal cannabis if the designated caregiver does not possess more than: 7 
(a) An amount of medicinal cannabis determined by the cabinet to constitute an 8 
uninterrupted thirty (30) day supply at his or her residence for each registered 9 
qualified patient to whom the caregiver is connected through the cabinet's 10 
registration process, except as permitted under Section 7 of this Act; 11 
(b) An amount of medicinal cannabis in excess of a thirty (30) day supply at his 12 
or her residence for each registered qualified patient to whom the caregiver is 13 
connected through the cabinet's registration process, in accordance with 14 
administrative regulations promulgated pursuant to KRS 218B.140(1)(c)6.; or 15 
(c) An amount of medicinal cannabis determined by the cabinet to constitute an 16 
uninterrupted ten (10) day supply on his or her person for each registered 17 
qualified patient to whom the caregiver is connected through the cabinet's 18 
registration process, except that an amount greater than a ten (10) day supply 19 
may be transported by a designated caregiver from a dispensary to his or her 20 
residence if the medicinal cannabis is contained in a sealed package that 21 
requires at least a two (2) step process for initial opening. 22 
(5) (a) All medicinal cannabis possessed by a cardholder outside of his or her 23 
residence shall be kept in the original container in which the cardholder 24 
received the medicinal cannabis from a dispensary. 25 
(b) When a cardholder possesses medicinal cannabis outside of his or her 26 
residence, the cardholder shall also be in possession of a valid registry 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 10 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
identification card issued by the cabinet or, for visiting qualified patients, a 1 
valid out-of-state registry identification card and documentation of having 2 
been diagnosed with a qualifying medical condition. 3 
(c) Paragraph (a) of this subsection shall not apply to medicinal cannabis that 4 
is the product of cultivation by a cardholder as permitted under Section 7 of 5 
this Act. 6 
(6) Notwithstanding subsections (1), (3), and (4) of this section and except as provided 7 
in administrative regulations promulgated pursuant to KRS 218B.140(1)(c)6.: 8 
(a) A registered qualified patient shall not be permitted to purchase more 9 
medicinal cannabis than the amount determined by the cabinet to constitute an 10 
uninterrupted thirty (30) day supply of medicinal cannabis during a given 11 
twenty-five (25) day period; 12 
(b) A designated caregiver shall not be permitted to purchase more medicinal 13 
cannabis than the amount determined by the cabinet to constitute an 14 
uninterrupted thirty (30) day supply of medicinal cannabis for each registered 15 
qualified patient to whom the caregiver is connected through the cabinet's 16 
registration process during a given twenty-five (25) day period; and 17 
(c) A visiting qualified patient shall not be permitted to purchase more medicinal 18 
cannabis than the amount determined by the cabinet to constitute an 19 
uninterrupted ten (10) day supply of medicinal cannabis during a given eight 20 
(8) day period. 21 
(7) A cardholder shall not be subject, under the laws of the Commonwealth, to arrest, 22 
prosecution, or denial of any right or privilege, including but not limited to a civil 23 
penalty or disciplinary action by a court or occupational or professional licensing 24 
board, for: 25 
(a) Possession of cannabis that is incidental to the use of medicinal cannabis; 26 
(b) Possession of medicinal cannabis accessories; or 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 11 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
(c) Transferring medicinal cannabis to a safety facility for testing. 1 
(8) No person shall be subject, under the laws of the Commonwealth, to arrest, 2 
prosecution, or denial of any right or privilege, including but not limited to a civil 3 
penalty or disciplinary action by a court or occupational or professional licensing 4 
board, for: 5 
(a) Selling medicinal cannabis accessories to a cardholder who is over eighteen 6 
(18) years of age upon presentation of a valid registry identification card 7 
issued by the cabinet or, for visiting qualified patients, a valid out-of-state 8 
registry identification card and documentation of having been diagnosed with 9 
a qualifying medical condition; 10 
(b) Being in the presence or vicinity of the use of medicinal cannabis as allowed 11 
under this chapter; or 12 
(c) Assisting a registered qualified patient or visiting qualified patient with using 13 
or administering medicinal cannabis. For purposes of illustration and not 14 
limitation, this includes preparing raw plant material or brewing tea for a 15 
registered qualified patient or visiting qualified patient. It does not include 16 
providing medicinal cannabis to a patient that the patient did not already 17 
possess. 18 
(9) Notwithstanding any other provision of law to the contrary, a registered qualified 19 
patient who is injured or defrauded, including by theft or deprivation of use and 20 
benefit of any money, personal property including medicinal cannabis, or articles of 21 
value of any kind, by his or her designated caregiver shall have a civil cause of 22 
action in Circuit Court to recover the actual damages sustained, together with the 23 
cost of the lawsuit, including a reasonable fee for the individual's attorney of record. 24 
Section 3.   KRS 218B.030 is amended to read as follows: 25 
(1) (a) Any medicinal cannabis, medicinal cannabis accessories, lawful property, or 26 
interest in lawful property that is possessed, owned, or used in connection 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 12 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
with the use of medicinal cannabis or acts incidental to that use shall not be 1 
subject to seizure or forfeiture under KRS 218A.405 to 218A.460. 2 
(b) This chapter shall not prevent the seizure or forfeiture of marijuana exceeding 3 
the amounts allowed under KRS 218B.025 and Section 7 of this Act or 4 
administrative regulations promulgated pursuant to KRS 218B.140(1)(c)6., 5 
nor shall it prevent seizure or forfeiture if the basis for that action is unrelated 6 
to the use of medicinal cannabis in accordance with this chapter and any 7 
administrative regulation promulgated thereunder. 8 
(2) Possession of, or application for, a registry identification card, an out-of-state 9 
registry identification card, or cannabis business license shall not constitute 10 
probable cause or reasonable suspicion, nor shall it be used to support the search of 11 
the person, property, or home of the person possessing or applying for the registry 12 
identification card, out-of-state registry identification card, or cannabis business 13 
license. The possession of, or application for, a registry identification card, out-of-14 
state registry identification card, or cannabis business license shall not preclude the 15 
existence of probable cause if probable cause exists on other grounds. 16 
(3) (a) There shall be a rebuttable presumption that a cardholder is engaged in the 17 
lawful use of medicinal cannabis, or in the case of a designated caregiver, 18 
assisting with the lawful use of medicinal cannabis, if the cardholder: 19 
1. Possesses a valid registry identification card or, in the case of a visiting 20 
qualified patient, an out-of-state registry identification card and 21 
documentation of having been diagnosed with a qualifying medical 22 
condition; and 23 
2. Possesses an amount of medicinal cannabis that does not exceed the 24 
amount allowed under KRS 218B.025 or administrative regulations 25 
promulgated pursuant to KRS 218B.140(1)(c)6. 26 
(b) This presumption may be rebutted by a preponderance of evidence that 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 13 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
conduct was unrelated to the use of medicinal cannabis or was otherwise in 1 
violation of this chapter. 2 
Section 4.   KRS 218B.035 is amended to read as follows: 3 
(1) This chapter does not authorize any person to engage in, and shall not prevent the 4 
imposition of any civil, criminal, or other penalties, including but not limited to 5 
criminal prosecution or disciplinary action by the cabinet or an occupational or 6 
professional licensing board, for engaging in the following conduct: 7 
(a) Operating, navigating, or being in actual physical control of any aircraft, 8 
vehicle, vessel, or any other device known, or hereafter invented, that is 9 
powered by machinery and that is or may be used to transport persons or 10 
property while under the influence of medicinal cannabis; 11 
(b) Consuming medicinal cannabis while operating, navigating, or being in actual 12 
physical control of an aircraft, vehicle, vessel, or any other device known, or 13 
hereafter invented, that is powered by machinery and that is or may be used to 14 
transport persons or property; 15 
(c) Possessing medicinal cannabis that is within the operator's arm's reach or 16 
requires less than a two (2) step process to access while operating, navigating, 17 
or being in actual physical control of an aircraft, vehicle, vessel, or any other 18 
device known, or hereafter invented, that is powered by machinery and that is 19 
or may be used to transport persons or property; 20 
(d) Undertaking any task under the influence of medicinal cannabis, when doing 21 
so would constitute negligence or professional malpractice; 22 
(e) Possessing medicinal cannabis, or otherwise engaging in the use of medicinal 23 
cannabis: 24 
1. On the grounds of any preschool or primary or secondary school, except 25 
as permitted in accordance with policies enacted pursuant to KRS 26 
218B.045(4); 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 14 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
2. In any correctional facility; or 1 
3. On any property of the federal government; 2 
(f) Using marijuana, if that person is not a registered qualified patient or visiting 3 
qualified patient; 4 
(g) Using or consuming marijuana by smoking, except as permitted under 5 
subsection (3) of this section; 6 
(h) Using or consuming marijuana by vaping while on any form of public 7 
transportation, in any public place as defined in KRS 525.010, or in any place 8 
of public accommodation, resort, or amusement as defined in KRS 344.130; 9 
or 10 
(i) Cultivating marijuana unless that person is licensed by the cabinet as a 11 
cannabis cultivator or cannabis producer pursuant to KRS 218B.080, 12 
218B.085, and 218B.090 or is a cultivator or producer agent, except as 13 
permitted in Section 7 of this Act. 14 
(2) The penalty for a violation of subsection (1)(a) or (b) of this section shall be the 15 
same as those established for operating a motor vehicle under the influence of 16 
alcohol or any other substance in KRS 189A.010. 17 
(3) (a) An individual who violates subsection (1)(g) or (h) of this section shall not be 18 
considered to be in possession of medicinal cannabis or engaged in the use of 19 
medicinal cannabis and shall not benefit from the legal protections afforded 20 
by this chapter. 21 
(b) A registered qualified patient shall not be considered to be in violation of 22 
subsection (1)(g) of this section if he or she uses or consumes medicinal 23 
cannabis by smoking while on private property owned by the registered 24 
qualified patient or his or her designated caregiver. 25 
(c) The odor or smell of uncombusted raw plant material shall not constitute 26 
evidence of use or consumption of cannabis by smoking. 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 15 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
(d)[(c)] If an individual uses or consumes marijuana by smoking or vaping while 1 
on any form of public transportation, in any public place as defined in KRS 2 
525.010, or in any place of public accommodation, resort, or amusement as 3 
defined in KRS 344.130: 4 
1. The cabinet may revoke the individual's registry identification card; and 5 
2. The individual may be subject to prosecution under KRS 218A.1421 6 
and 218A.1422. 7 
(4) Nothing in this chapter supersedes statutory laws relating to driving while under the 8 
influence of intoxicants. This chapter shall not prevent the enforcement of current 9 
laws pertaining to driving while intoxicated, including KRS 183.061, 189.520, 10 
189A.010, and 235.240. 11 
(5) As used in this section: 12 
(a) "Aircraft" has the same meaning as in KRS 183.011; 13 
(b) "Vehicle" has the same meaning as in KRS 189.010; and 14 
(c) "Vessel" has the same meaning as in KRS 235.010. 15 
Section 5.   KRS 218B.080 is amended to read as follows: 16 
(1) No person shall cultivate, except as permitted under Section 7 of this Act, process, 17 
produce, possess, test, transfer, transport, or sell medicinal cannabis or otherwise 18 
operate a cannabis business in this state without first obtaining a license under this 19 
section. 20 
(2) The cabinet shall create separate licenses, licensure application fees, initial 21 
licensure fees, and licensure renewal fees allowing persons to operate a cannabis 22 
business, pursuant to this chapter and any administrative regulations promulgated 23 
thereunder, as a: 24 
(a) Tier I cannabis cultivator; 25 
(b) Tier II cannabis cultivator; 26 
(c) Tier III cannabis cultivator; 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 16 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
(d) Tier IV cannabis cultivator; 1 
(e) Cannabis dispensary; 2 
(f) Cannabis processor; 3 
(g) Cannabis producer; or 4 
(h) Cannabis safety compliance facility. 5 
(3) Licensure application fees, initial licensing fees, and licensure renewal fees 6 
collected by the cabinet pursuant to this section shall be retained by the cabinet for 7 
administrative purposes. 8 
(4) (a) Except as provided in paragraph (b) of this subsection, a cannabis business 9 
shall be required to apply for and obtain from the cabinet a separate license 10 
for each location it intends to operate. 11 
(b) A cannabis business licensed as a producer may operate cultivation and 12 
processing activities at separate locations, but shall not operate more than one 13 
(1) cultivation and one (1) processing facility per license. 14 
(5) (a) A cannabis business license issued under this section and KRS 218B.085 and 15 
218B.090 shall be valid for one (1) year from the date of issuance. The 16 
cabinet shall notify each licensee ninety (90) days prior to the date the license 17 
expires to allow the licensee to begin the renewal process established by the 18 
cabinet pursuant to KRS 218B.140. 19 
(b) The renewal of a cannabis business license shall be contingent upon 20 
successful achievement of minimal performance standards established by the 21 
cabinet as part of the biennial accreditation process established by the cabinet 22 
pursuant to KRS 218B.140. 23 
(6) The cabinet shall approve a license holder's sale of a license issued pursuant to this 24 
section and KRS 218B.085 and 218B.090 if the purchaser and any new facilities 25 
meet the requirements of this chapter. 26 
Section 6.   KRS 218B.140 is amended to read as follows: 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 17 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
(1) No later than July 1, 2024, the cabinet shall: 1 
(a) Ensure that the electronic monitoring system established pursuant to KRS 2 
218A.202 is designed or configured to enable: 3 
1. Medicinal cannabis practitioners to record the issuance of written 4 
certifications to qualified patients, as required by KRS 218B.050; 5 
2. The cabinet and state licensing boards to monitor the issuance of written 6 
certifications by medicinal cannabis practitioners; 7 
3. Cabinet personnel, law enforcement personnel, and dispensary agents to 8 
verify the validity of registry identification cards issued by the cabinet 9 
by entering a registry identification number to determine whether or not 10 
the identification number corresponds with a current, valid registry 11 
identification card. The system shall only disclose whether the 12 
identification card is valid and whether the cardholder is a registered 13 
qualified patient, visiting qualified patient, or designated caregiver; 14 
4. Law enforcement personnel and dispensary agents to access medicinal 15 
cannabis sales data recorded by dispensary agents pursuant to KRS 16 
218B.110; 17 
5. Dispensary agents to record the amount of medicinal cannabis that is 18 
dispensed to a cardholder during each transaction as required by KRS 19 
218B.110; and 20 
6. The sharing of dispensing data recorded by dispensary agents pursuant 21 
to KRS 218B.110 with all dispensaries in real time; 22 
(b) Ensure that the electronic monitoring system established pursuant to KRS 23 
218A.202 is designed to facilitate the tracking of medicinal cannabis 24 
cultivated, processed, or produced by a licensed cannabis business from the 25 
point of cultivation to the point of sale to cardholders; and 26 
(c) Promulgate administrative regulations in accordance with KRS Chapter 13A 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 18 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
to establish: 1 
1. Procedures for the issuance, renewal, suspension, and revocation of 2 
registry identification cards, including the creation of a standardized: 3 
a. Written certification form; and 4 
b. Application form which the cabinet shall require to be notarized; 5 
2. Procedures for the issuance and revocation of registry identification 6 
cards; 7 
3. Procedures for the issuance, renewal, suspension, and revocation of 8 
cannabis business licenses, including the creation of a uniform licensure 9 
application form which the cabinet shall require to be notarized and 10 
minimal performance standards for a biennial accreditation process with 11 
all such procedures subject to the requirements of KRS Chapters 13A 12 
and 13B; 13 
4. A convenience fee to be assessed and collected by dispensaries for 14 
visiting qualified patients who do not possess a valid registry 15 
identification card issued by the cabinet and who purchase medicinal 16 
cannabis with an out-of-state registry identification card and 17 
documentation of having been diagnosed with a qualifying medical 18 
condition. The convenience fee established pursuant to this 19 
subparagraph shall not exceed fifteen dollars ($15) per transaction; 20 
5. In collaboration with the Board of Physicians and Advisors: 21 
a. A definition of the amount of medicinal cannabis or delta-9 22 
tetrahydrocannabinol that constitutes a daily supply, an 23 
uninterrupted ten (10) day supply, and an uninterrupted thirty (30) 24 
day supply of medicinal cannabis; and 25 
b. The amount of raw plant material that medicinal cannabis products 26 
are considered to be equivalent to; 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 19 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
6. A process by which a medicinal cannabis practitioner may recommend, 1 
and a registered qualified patient or his or her designated caregiver may 2 
legally purchase and possess, an amount of medicinal cannabis in excess 3 
of the thirty (30) day supply of medicinal cannabis, if the medicinal 4 
cannabis practitioner reasonably believes that the standard thirty (30) 5 
day supply would be insufficient in providing the patient with 6 
uninterrupted therapeutic or palliative relief; 7 
7. Provisions governing the following matters related to cannabis 8 
businesses with the goal of protecting against diversion and theft, 9 
without imposing any undue burden that would make cannabis business 10 
operations unreasonable or impractical on cannabis businesses or 11 
compromising the confidentiality of cardholders: 12 
a. Recordkeeping and inventory control requirements, including the 13 
use of the electronic monitoring systems established pursuant to 14 
KRS 218A.202; 15 
b. Procedures for the verification and validation of a registry 16 
identification card, or its equivalent, that was issued pursuant to 17 
the laws of another state, district, territory, commonwealth, or 18 
insular possession of the United States that allows for the use of 19 
medicinal cannabis in the jurisdiction of issuance; 20 
c. Security requirements for safety compliance facilities, processors, 21 
producers, dispensaries, and cultivators, which shall include at a 22 
minimum lighting, video security, alarm requirements, on-site 23 
parking, and measures to prevent loitering; 24 
d. Procedures for the secure transportation, including delivery 25 
services provided by dispensaries, and storage of medicinal 26 
cannabis by cannabis business licensees and their employees or 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 20 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
agents; 1 
e. Employment and training requirements for licensees and their 2 
agents, including requiring each licensee to create an identification 3 
badge for each of the licensee's agents or employees; and 4 
f. Restrictions on visits to licensed cultivation and processing 5 
facilities, including requiring the use of visitor logs; 6 
8. Procedures to establish, publish, and annually update a list of varieties 7 
of cannabis that possess a low but effective level of 8 
tetrahydrocannabinol, including the substance cannabidiol, by 9 
comparing percentages of chemical compounds within a given variety 10 
against other varieties of cannabis; 11 
9. A rating system that tracks the terpene content of at least the twelve (12) 12 
major terpenoids within each strain of cannabis available for medicinal 13 
use within the Commonwealth; 14 
10. Requirements for random sample testing of medicinal cannabis to 15 
ensure quality control, including testing for cannabinoids, terpenoids, 16 
residual solvents, pesticides, poisons, toxins, mold, mildew, insects, 17 
bacteria, and any other dangerous adulterant; 18 
11. Requirements for licensed cultivators, producers, and processors to 19 
contract with an independent safety compliance facility to test the 20 
medicinal cannabis before it is sold at a dispensary. The cabinet may 21 
approve the safety compliance facility chosen by a cultivator, producer, 22 
or processor and require that the safety compliance facility report test 23 
results for a designated quantity of medicinal cannabis to the cultivator, 24 
producer, or processor and cabinet; 25 
12. Standards for the operation of safety compliance facilities which may 26 
include: 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 21 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
a. Requirements for equipment; 1 
b. Personnel qualifications; and 2 
c. Requiring facilities to be accredited by a relevant certifying entity; 3 
13. Standards for the packaging and labeling of medicinal cannabis sold or 4 
distributed by cannabis businesses which shall comply with 15 U.S.C. 5 
secs. 1471 to 1476 and shall include: 6 
a. Standards for packaging that requires at least a two (2) step 7 
process of initial opening; 8 
b. A warning label which may include the length of time it typically 9 
takes for the product to take effect, how long the effects of the 10 
product typically last, and any other information deemed 11 
appropriate or necessary by the cabinet; 12 
c. The amount of medicinal cannabis the product is considered the 13 
equivalent to; 14 
d. Disclosing ingredients, possible allergens, and certain bioactive 15 
components, including cannabinoids and terpenoids, as determined 16 
by the cabinet; 17 
e. A nutritional fact panel; 18 
f. Opaque, child-resistant packaging; 19 
g. [A requirement that all raw plant material packaged or sold in this 20 
state be marked or labeled as "NOT INTENDED FOR 21 
CONSUMPTION BY SMOKING"; 22 
h. ]A requirement that medicinal cannabis products be clearly 23 
marked with an identifiable and standardized symbol indicating 24 
that the product contains cannabis; 25 
h.[i.] A requirement that all medicinal cannabis product packaging 26 
include an expiration date; and 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 22 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
i.[j.] A requirement that medicinal cannabis products and their 1 
packaging not be visually reminiscent of major brands of edible 2 
noncannabis products or otherwise present an attractive nuisance 3 
to minors; 4 
14. Health and safety requirements for the processing of medicinal cannabis 5 
and the indoor cultivation of medicinal cannabis by licensees; 6 
15. Restrictions on: 7 
a. Additives to medicinal cannabis that are toxic, including vitamin E 8 
acetate, or increase the likelihood of addiction; and 9 
b. Pesticides, fertilizers, and herbicides used during medicinal 10 
cannabis cultivation which pose a threat to human health and 11 
safety; 12 
16. Standards for the safe processing of medicinal cannabis products created 13 
by extracting or concentrating compounds from raw plant material; 14 
17. Standards for determining the amount of unprocessed raw plant material 15 
that medicinal cannabis products are considered the equivalent to; 16 
18. Restrictions on advertising, marketing, and signage in regard to 17 
operations or establishments owned by licensees necessary to prevent 18 
the targeting of minors; 19 
19. The requirement that evidence-based educational materials regarding 20 
dosage and impairment be disseminated to registered qualified patients, 21 
visiting qualified patients, and designated caregivers who purchase 22 
medicinal cannabis products; 23 
20. Policies governing insurance requirements for cultivators, dispensaries, 24 
processors, producers, and safety compliance facilities; and 25 
21. Standards, procedures, or restrictions that the cabinet deems necessary 26 
to ensure the efficient, transparent, and safe operation of the medicinal 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 23 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
cannabis program, except that the cabinet shall not promulgate any 1 
administrative regulation that would impose an undue burden or make 2 
cannabis business operations unreasonable or impractical. 3 
(2) No later than January 1, 2025, the cabinet shall: 4 
(a) Establish a medicinal cannabis adverse drug effects reporting system for the 5 
purpose of allowing cardholders to report adverse drug effects via telephone 6 
or online; and 7 
(b) In collaboration with the Board of Physicians and Advisors, produce the 8 
Medicinal Cannabis Advisory Pamphlet which shall include but not be limited 9 
to: 10 
1. Information on the risks, dangers, and possible side effects of the use of 11 
medicinal cannabis; 12 
2. Information on the medicinal cannabis adverse drug effects reporting 13 
system and how to report adverse drug effects; and 14 
3. A detachable signature page which shall be: 15 
a. Signed by a cardholder each time he or she receives a copy of the 16 
Medicinal Cannabis Advisory Pamphlet as required under KRS 17 
218B.110(2)(d); and 18 
b. Retained by the dispensary for a period of at least thirty-six (36) 19 
months. 20 
(3) The cabinet shall provide each licensed dispensary with an adequate number of 21 
Medicinal Cannabis Advisory Pamphlets to ensure that the dispensary is able to 22 
comply with the requirements of KRS 218B.110(2)(d). 23 
(4) Except as provided in KRS 218B.035(1)(g), 218B.095(2)(b), 218.110(2)(e), 24 
218B.115(2), 218B.120(3), and subsection (1)(c)10., 13., 15., and 16. of this 25 
section, the cabinet shall not restrict or limit methods of delivery, use, or 26 
consumption of medicinal cannabis or the types of products that may be acquired, 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 24 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
produced, processed, possessed, sold, or distributed by a cannabis business. 1 
(5) If a need for additional cannabis cultivation in this state is demonstrated by 2 
cannabis businesses or the cabinet's own analysis, the cabinet may through the 3 
promulgation of administrative regulations increase the cultivation area square 4 
footage limits for either cultivators or producers, or both by up to three (3) times the 5 
limits established in KRS 218B.105 and 218B.120. Any increase in the cultivation 6 
square footage limits adopted by the cabinet pursuant to this section shall not result 7 
in an increase in the licensure application or renewal fees established by the cabinet. 8 
(6) When promulgating administrative regulations under this section, the cabinet shall 9 
consider standards, procedures, and restrictions that have been found to be best 10 
practices relative to the use and regulation of medicinal cannabis. 11 
SECTION 7.   A NEW SECTION OF KRS CHAPTER 218B IS CREATED TO 12 
READ AS FOLLOWS: 13 
(1) Notwithstanding any provision of law to the contrary, in addition to the 14 
possession limits established in subsections (1)(a) and 4(a) of Section 2 of this 15 
Act: 16 
(a) 1. A registered qualified patient who is at least eighteen (18) years of age 17 
shall be permitted to possess, cultivate, and harvest up to three (3) 18 
mature medicinal cannabis plants and up to three (3) seedlings on 19 
private property owned by the registered qualified patient. 20 
2. A designated caregiver shall be permitted to possess, cultivate, and 21 
harvest up to three (3) mature medicinal cannabis plants and up to 22 
three (3) seedlings for each registered qualified patient to whom the 23 
designated caregiver is connected through the cabinet's registration 24 
process on private property owned by the designated caregiver; and 25 
(b) Cardholders who possess, cultivate, and harvest mature medicinal cannabis 26 
plants and seedlings shall be permitted to possess, on private property they 27  UNOFFICIAL COPY  	25 RS BR 1303 
Page 25 of 25 
XXXX   1/30/2025 11:06 AM  	Jacketed 
own, any amount of raw plant material and medicinal cannabis products 1 
resulting from at-home cultivation activities permitted under this section. 2 
(2) Cardholders who wish to possess, cultivate, and harvest medicinal cannabis 3 
plants and seedlings shall not be required under this chapter or by any 4 
administrative regulation promulgated by the cabinet to register or otherwise 5 
notify the cabinet of their intent to possess, cultivate, and harvest medicinal 6 
cannabis plants and seedlings on private property they own. 7 
(3) Mature medicinal cannabis plants and seedlings possessed, cultivated, and 8 
harvested by cardholders shall be stored in an enclosed, locked space such as a 9 
closet, room, greenhouse, or other indoor locked space located on private 10 
property owned by the cardholder. 11 
(4) The concentration and potency limits for commercially available medicinal 12 
cannabis established in KRS 218B.095, 218B.110, 218B.115, and 218B.120 shall 13 
not apply to raw plant material or medicinal cannabis products resulting from at-14 
home cultivation activities permitted under this section. 15 
(5) (a) Except for a designated caregiver who may provide medicinal cannabis to a 16 
registered qualified patient to whom they are connected through the 17 
cabinet's registration process, nothing in this section shall be interpreted as 18 
authorizing or otherwise permitting a cardholder to transfer or sell 19 
medicinal cannabis, mature medicinal cannabis plants, or seedlings to 20 
another individual including another cardholder. 21 
(b) A cardholder who transfers or sells medicinal cannabis, mature medicinal 22 
cannabis plants, or seedlings to another individual in violation of paragraph 23 
(a) of this subsection, may be subject to prosecution including under KRS 24 
218A.1421. 25